Physician profile
Caleb Yeung
NPI 1649629940
$6,764.47
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $2,033 · 2023: $3,652 · 2024: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,604 · Food and Beverage: $2,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,603.51 |
| Food and Beverage | $2,024.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,521.78 | 2021-2024 | N/A, Chesapeake Stabilization System |
| Medical Device Business Services, INC. | $1,343.69 | 2022 | |
| Globus Medical, INC. | $1,303.43 | 2023 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System |
| Medtronic, INC. | $578.76 | 2023-2024 | Mazor X System, Intellis Adaptivestim, Stealthstation S8 Platform |
| Cerapedics INC. | $192.27 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Nevro Corp. | $190.77 | 2024 | Senza |
| Depuy Synthes Sales INC. | $179.84 | 2022-2023 | Teligen, Conduit, Viper |
| Arteriocyte Medical Systems, INC. | $176.81 | 2024 | Magellan |
| Zimvie INC. | $132.02 | 2023 | |
| Baxter Healthcare | $130.80 | 2024 | Tisseel |
| Nuvasive, INC. | $14.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Yeung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.